Overexpression of Wild-Type but Not C134W Mutant FOXL2 Enhances GnRH-Induced Cell Apoptosis by Increasing GnRH Receptor Expression in Human Granulosa Cell Tumors

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Cheng, Jung Chien ^a   Klausen, Christian ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXL2 PROTEIN; GONADORELIN; GONADORELIN RECEPTOR; PROTEIN; RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; DOWN REGULATION; FOXL2 GENE; GENE; GENE MUTATION; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROTEIN EXPRESSION; RNA INTERFERENCE; WILD TYPE;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GONADOTROPIN-RELEASING HORMONE; GRANULOSA CELL TUMOR; HUMANS; MUTATION; OVARIAN NEOPLASMS; RECEPTORS, LHRH;

EID: 84872810945     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055099     Document Type: Article

References (30)

1. Schumer ST, Cannistra SA, (2003) Granulosa cell tumor of the ovary. J Clin Oncol 21: 1180-1189.
2. Cheng CK, Leung PC, (2005) Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 26: 283-306.
3. Choi JH, Gilks CB, Auersperg N, Leung PC, (2006) Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary. J Clin Endocrinol Metab 91: 4562-4570.
4. Cheng CK, Yeung CM, Chow BK, Leung PC, (2002) Characterization of a new upstream GnRH receptor promoter in human ovarian granulosa-luteal cells. Mol Endocrinol 16: 1552-1564.
5. Hong IS, Cheung AP, Leung PC, (2008) Gonadotropin-releasing hormones I and II induce apoptosis in human granulosa cells. J Clin Endocrinol Metab 93: 3179-3185.
6. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al. (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27: 159-166.
7. Stromme P, Sandboe F, (1996) Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Acta Ophthalmol Scand 74: 45-47.
8. Zlotogora J, Sagi M, Cohen T, (1983) The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet 35: 1020-1027.
9. De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, et al. (2001) Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet 10: 1591-1600.
10. Shah SP, Kobel M, Senz J, Morin RD, Clarke BA, et al. (2009) Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360: 2719-2729.
11. Lee K, Pisarska MD, Ko JJ, Kang Y, Yoon S, et al. (2005) Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis. Biochem Biophys Res Commun 336: 876-881.
12. Kim JH, Yoon S, Park M, Park HO, Ko JJ, et al. (2011) Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W). Oncogene 30: 1653-1663.
13. Batista F, Vaiman D, Dausset J, Fellous M, Veitia RA, (2007) Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc Natl Acad Sci U S A 104: 3330-3335.
14. Ellsworth BS, Burns AT, Escudero KW, Duval DL, Nelson SE, et al. (2003) The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein. Mol Cell Endocrinol 206: 93-111.
15. Schrader KA, Gorbatcheva B, Senz J, Heravi-Moussavi A, Melnyk N, et al. (2009) The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors. PLoS One 4: e7988.
16. Nishi Y, Yanase T, Mu Y, Oba K, Ichino I, et al. (2001) Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142: 437-445.
17. Lie BL, Leung E, Leung PC, Auersperg N, (1996) Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol Cell Endocrinol 120: 169-176.
18. Pisarska MD, Bae J, Klein C, Hsueh AJ, (2004) Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 145: 3424-3433.
19. Poon SL, Hammond GT, Leung PC, (2009) Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion. Mol Endocrinol 23: 1646-1656.
20. Kim KY, Choi KC, Auersperg N, Leung PC, (2006) Mechanism of gonadotropin-releasing hormone (GnRH)-I and-II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway. Endocr Relat Cancer 13: 211-220.
21. Park DW, Choi KC, MacCalman CD, Leung PC, (2009) Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase. Reprod Biol Endocrinol 7: 81.
22. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, et al. (2004) The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131: 933-942.
23. Billig H, Furuta I, Hsueh AJ, (1994) Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology 134: 245-252.
24. Escudero JM, Haller JL, Clay CM, Escudero KW, (2010) Microarray analysis of Foxl2 mediated gene regulation in the mouse ovary derived KK1 granulosa cell line: Over-expression of Foxl2 leads to activation of the gonadotropin releasing hormone receptor gene promoter. J Ovarian Res 3: 4.
25. Ngan ES, Cheng PK, Leung PC, Chow BK, (1999) Steroidogenic factor-1 interacts with a gonadotrope-specific element within the first exon of the human gonadotropin-releasing hormone receptor gene to mediate gonadotrope-specific expression. Endocrinology 140: 2452-2462.
26. Fleming NI, Knower KC, Lazarus KA, Fuller PJ, Simpson ER, et al. (2010) Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter. PLoS One 5: e14389.
27. Rosario R, Araki H, Print CG, Shelling AN, (2012) The transcriptional targets of mutant FOXL2 in granulosa cell tumours. PLoS One 7: e46270.
28. L'Hote D, Georges A, Todeschini AL, Kim JH, Benayoun BA, et al. (2012) Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles. Hum Mol Genet 21: 3264-3274.
29. Obsil T, Obsilova V, (2008) Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 27: 2263-2275.
30. Benayoun BA, Caburet S, Dipietromaria A, Georges A, D'Haene B, et al. (2010) Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS One 5: e8789.